Citations (94)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
John G. Baust, Kristi K. Snyder, Kimberly L. Santucci, Anthony T. Robilotto, Robert G. Van Buskirk & John M. Baust. (2019) Cryoablation: physical and molecular basis with putative immunological consequences. International Journal of Hyperthermia 36:sup1, pages 10-16.
Read now
Read now
Sarah Benafif & Marcia Hall. (2015) An update on PARP inhibitors for the treatment of cancer. OncoTargets and Therapy 8, pages 519-528.
Read now
Read now
Stephanie Lheureux, Michelle Wilson & Helen J Mackay. (2014) Recent and current Phase II clinical trials in endometrial cancer: review of the state of art. Expert Opinion on Investigational Drugs 23:6, pages 773-792.
Read now
Read now
Rachel Abbotts, Nicola Thompson & Srinivasan Madhusudan. (2014) DNA repair in cancer: emerging targets for personalized therapy. Cancer Management and Research 6, pages 77-92.
Read now
Read now
Byeong Choi, Chang-Yan Chen & Wei Dai. (2013) Chromatin PTEN is involved in DNA damage response partly through regulating Rad52 sumoylation. Cell Cycle 12:21, pages 3442-3447.
Read now
Read now
Mary Leonard, Natasha Hill, Paula Bubulya & Madhavi Kadakia. (2013) The PTEN-Akt pathway impacts the integrity and composition of mitotic centrosomes. Cell Cycle 12:9, pages 1406-1415.
Read now
Read now
Mayank Singh, Clayton R. Hunt, Raj K. Pandita, Rakesh Kumar, Chin-Rang Yang, Nobuo Horikoshi, Robert Bachoo, Sara Serag, Michael D. Story, Jerry W. Shay, Simon N. Powell, Arun Gupta, Jessie Jeffery, Shruti Pandita, Benjamin P. C. Chen, Dorothee Deckbar, Markus Löbrich, Qin Yang, Kum Kum Khanna, Howard J. Worman & Tej K. Pandita. (2013) Lamin A/C Depletion Enhances DNA Damage-Induced Stalled Replication Fork Arrest. Molecular and Cellular Biology 33:6, pages 1210-1222.
Read now
Read now
Linda S. Steelman, Patrick Navolanic, William H. Chappell, Stephen L. Abrams, Ellis W.T. Wong, Alberto M. Martelli, Lucio Cocco, Franca Stivala, Massimo Libra, Ferdinando Nicoletti, Lyudmyla B. Drobot, Richard A. Franklin & James A. McCubrey. (2011) Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells. Cell Cycle 10:17, pages 3003-3015.
Read now
Read now
Konstantin J. Dedes, Paul M. Wilkerson, Daniel Wetterskog, Britta Weigelt, Alan Ashworth & Jorge S. Reis-Filho. (2011) Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations. Cell Cycle 10:8, pages 1192-1199.
Read now
Read now
Girdhar G. Sharma, Sairei So, Arun Gupta, Rakesh Kumar, Christelle Cayrou, Nikita Avvakumov, Utpal Bhadra, Raj K. Pandita, Matthew H. Porteus, David J. Chen, Jacques Cote & Tej K. Pandita. (2010) MOF and Histone H4 Acetylation at Lysine 16 Are Critical for DNA Damage Response and Double-Strand Break Repair. Molecular and Cellular Biology 30:14, pages 3582-3595.
Read now
Read now
Articles from other publishers (84)
Jian-Lei Zhao, Jun Yang, Ke Li, Yang Chen, Mei Tang, Hui-Li Zhu, Chun-Lai Nie, Zhu Yuan & Xin-Yu Zhao. (2023) Abrogation of ATR function preferentially augments cisplatin-induced cytotoxicity in PTEN-deficient breast cancer cells. Chemico-Biological Interactions 385, pages 110740.
Crossref
Crossref
Goutam Kumar Tanti, Prachi Pandey, Smriti Shreya & Buddhi Prakash Jain. (2023) Striatin family proteins: The neglected scaffolds. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1870:3, pages 119430.
Crossref
Crossref
Xile Pei, Emil Mladenov, Aashish Soni, Fanghua Li, Martin Stuschke & George Iliakis. (2022) PTEN Loss Enhances Error-Prone DSB Processing and Tumor Cell Radiosensitivity by Suppressing RAD51 Expression and Homologous Recombination. International Journal of Molecular Sciences 23:21, pages 12876.
Crossref
Crossref
Rabia Rasool, Inam Ullah, Bismillah Mubeen, Sultan Alshehri, Syed Sarim Imam, Mohammed M. Ghoneim, Sami I. Alzarea, Fahad A. Al-Abbasi, Bibi Nazia Murtaza, Imran Kazmi & Muhammad Shahid Nadeem. (2022) Theranostic Interpolation of Genomic Instability in Breast Cancer. International Journal of Molecular Sciences 23:3, pages 1861.
Crossref
Crossref
Jingyi Tang, Patrick J Casey & Mei Wang. (2021) Suppression of isoprenylcysteine carboxylmethyltransferase compromises DNA damage repair. Life Science Alliance 4:12, pages e202101144.
Crossref
Crossref
Christian Bassi, Jerome Fortin, Bryan E. Snow, Andrew Wakeham, Jason Ho, Jillian Haight, Annick You-Ten, Emily Cianci, Luke Buckler, Chiara Gorrini, Vuk Stambolic & Tak W. Mak. (2021) The PTEN and ATM axis controls the G1/S cell cycle checkpoint and tumorigenesis in HER2-positive breast cancer. Cell Death & Differentiation 28:11, pages 3036-3051.
Crossref
Crossref
Asha Sinha, Ali Saleh, Raelene Endersby, Shek H. Yuan, Chirayu R. Chokshi, Kevin R. Brown, Bozena Kuzio, Tiina Kauppinen, Sheila K. Singh, Suzanne J. Baker, Peter J. McKinnon & Sachin Katyal. (2020) RAD51-Mediated DNA Homologous Recombination Is Independent of PTEN Mutational Status. Cancers 12:11, pages 3178.
Crossref
Crossref
Xinyi Fan, Jeffrey Kraynak, Jonathan P.S. Knisely, Silvia C. Formenti & Wen H. Shen. (2020) PTEN as a Guardian of the Genome: Pathways and Targets. Cold Spring Harbor Perspectives in Medicine 10:9, pages a036194.
Crossref
Crossref
Nneoma Adaku, Hyun Bong Park, Daniel J. Spakowicz, Meetu Kaushik Tiwari, Scott A. Strobel, Jason M. Crawford & Faye A. Rogers. (2020) A DNA Repair Inhibitor Isolated from an Ecuadorian Fungal Endophyte Exhibits Synthetic Lethality in PTEN-Deficient Glioblastoma. Journal of Natural Products 83:6, pages 1899-1908.
Crossref
Crossref
Mu-Yan Cai, Connor E. Dunn, Wenxu Chen, Bose S. Kochupurakkal, Huy Nguyen, Lisa A. Moreau, Geoffrey I. Shapiro, Kalindi Parmar, David Kozono & Alan D. D’Andrea. (2020) Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection. Cell Reports 30:7, pages 2402-2415.e5.
Crossref
Crossref
Emilio Hirsch, Federico Gulluni & Miriam Martini. (2020) Phosphoinositides in cell proliferation and metabolism. Advances in Biological Regulation 75, pages 100693.
Crossref
Crossref
Leon P. Bignold. 2020. Principles of Tumors. Principles of Tumors
389
418
.
D. A. Chebotarev, M. A. Makhotkin, A. V. Naboka, M. G. Tyutyakina, E. N. Cherkasova & V. A. Tarasov. (2019) Involvement of MicroRNAs in Regulation of Radioresistance of HeLa and DU145 Cells. Russian Journal of Genetics 55:9, pages 1072-1081.
Crossref
Crossref
Douglas W. Yao, Nikolas G. Balanis, Eleazar Eskin & Thomas G. Graeber. (2019) A linear mixed model approach to gene expression-tumor aneuploidy association studies. Scientific Reports 9:1.
Crossref
Crossref
Tingting Zhang, Xiang Xue & Huixia Peng. (2019) Therapeutic Delivery of miR-29b Enhances Radiosensitivity in Cervical Cancer. Molecular Therapy 27:6, pages 1183-1194.
Crossref
Crossref
Xuan Jiang, Xiaoying Li, Weihua Li, Huimin Bai & Zhenyu Zhang. (2019) PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms. Journal of Cellular and Molecular Medicine 23:4, pages 2303-2313.
Crossref
Crossref
Audrey Turchick, Yanfeng Liu, Weixi Zhao, Inessa Cohen & Peter M. Glazer. (2019) Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cells. Oncotarget 10:13, pages 1272-1283.
Crossref
Crossref
Gabriel S. Macedo, Barbara Alemar & Patricia Ashton-Prolla. (2019) Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era. Genetics and Molecular Biology 42:1 suppl 1, pages 215-231.
Crossref
Crossref
Michael Fraser & Alexandre Rouette. 2019. Prostate Cancer. Prostate Cancer
87
110
.
M. S. Rashid, T. Mazur, W. Ji, S. T. Liu & W. R. Taylor. (2018) Analysis of the role of GSK3 in the mitotic checkpoint. Scientific Reports 8:1.
Crossref
Crossref
Parker L. Sulkowski, Susan E. Scanlon, Sebastian Oeck & Peter M. Glazer. (2018) PTEN Regulates Nonhomologous End Joining By Epigenetic Induction of NHEJ1/XLF. Molecular Cancer Research 16:8, pages 1241-1254.
Crossref
Crossref
Ke Li, Huaying Yan, Wenhao Guo, Mei Tang, Xinyu Zhao, Aiping Tong, Yong Peng, Qintong Li & Zhu Yuan. (2018) ATM inhibition induces synthetic lethality and enhances sensitivity of PTEN-deficient breast cancer cells to cisplatin. Experimental Cell Research 366:1, pages 24-33.
Crossref
Crossref
W. Y. Mansour, P. Tennstedt, J. Volquardsen, C. Oing, M. Kluth, C. Hube-Magg, K. Borgmann, R. Simon, C. Petersen, E. Dikomey & K. Rothkamm. (2018) Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer. Scientific Reports 8:1.
Crossref
Crossref
A. Lester, R. Rapkins, S. Nixdorf, M. Khasraw & K. McDonald. (2016) Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?. Clinical and Translational Oncology 19:3, pages 273-278.
Crossref
Crossref
Reem Ali, Emad A. Rakha, Srinivasan Madhusudan & Helen E. Bryant. (2017) DNA damage repair in breast cancer and its therapeutic implications. Pathology 49:2, pages 156-165.
Crossref
Crossref
Masaya Baba, Laura S. Schmidt & W. Marston Linehan. 2017. Renal Cell Carcinoma. Renal Cell Carcinoma
19
82
.
Kimberly L. Santucci, John M. Baust, Kristi K. Snyder, Anthony Robilotto, Robert G. VanBuskirk & John G. Baust. 2017. Imaging and Focal Therapy of Early Prostate Cancer. Imaging and Focal Therapy of Early Prostate Cancer
385
397
.
Finn Cilius Nielsen, Thomas van Overeem Hansen & Claus Storgaard Sørensen. (2016) Hereditary breast and ovarian cancer: new genes in confined pathways. Nature Reviews Cancer 16:9, pages 599-612.
Crossref
Crossref
Meng Li, Zhongmin Peng, Wangang Ren & Zhou Wang. (2016) Small activating ribonucleic acid reverses tyrosine kinase inhibitor resistance in epidermal growth factor receptor‐mutant lung cancer by increasing the expression of phosphatase and tensin homolog. Thoracic Cancer 7:4, pages 481-485.
Crossref
Crossref
Nobuo Horikoshi, Raj K. Pandita, Kalpana Mujoo, Shashank Hambarde, Dharmendra Sharma, Abid R. Mattoo, Sharmistha Chakraborty, Vijaya Charaka, Clayton R. Hunt & Tej K. Pandita. (2016) β2-spectrin depletion impairs DNA damage repair. Oncotarget 7:23, pages 33557-33570.
Crossref
Crossref
Ruopeng Zhang, Li Zhu, Lirong Zhang, Anli Xu, Zhengwei Li, Yijuan Xu, Pei He, Maoqing Wu, Fengxiang Wei & Chenhong Wang. (2016) PTEN enhances G2/M�arrest in etoposide-treated MCF‑7 cells through activation of the ATM pathway. Oncology Reports.
Crossref
Crossref
Saeed Rafii, Stan Kaye & Susana Banerjee. 2015. Targeted Therapy in Translational Cancer Research. Targeted Therapy in Translational Cancer Research
325
340
.
Carlo C. Campa, Miriam Martini, Maria C. De Santis & Emilio Hirsch. (2015) How PI3K-derived lipids control cell division. Frontiers in Cell and Developmental Biology 3.
Crossref
Crossref
Jinxue He, Xi Kang, Yuxin Yin, K. S. Clifford Chao & Wen H. Shen. (2015) PTEN regulates DNA replication progression and stalled fork recovery. Nature Communications 6:1.
Crossref
Crossref
Nuala McCabe, Conor Hanna, Steven M. Walker, David Gonda, Jie Li, Katarina Wikstrom, Kienan I. Savage, Karl T. Butterworth, Clark Chen, D. Paul Harkin, Kevin M. Prise & Richard D. Kennedy. (2015) Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATM. Cancer Research 75:11, pages 2159-2165.
Crossref
Crossref
Philip W. Noble, Grace Chan, Melissa R. Young, Richard H. Weisbart & James E. Hansen. (2015) Optimizing a Lupus Autoantibody for Targeted Cancer Therapy. Cancer Research 75:11, pages 2285-2291.
Crossref
Crossref
Luc G. T. Morris & Timothy A. Chan. (2015) Therapeutic targeting of tumor suppressor genes. Cancer 121:9, pages 1357-1368.
Crossref
Crossref
Laura R. H. Ip, George Poulogiannis, Felipe Cia Viciano, Junko Sasaki, Satoshi Kofuji, Victoria J. Spanswick, Daniel Hochhauser, John A. Hartley, Takehiko Sasaki & Christina A. Gewinner. (2015) Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment. Oncotarget 6:12, pages 10548-10562.
Crossref
Crossref
Helen E. Bryant & Sydney Shall. 2015. PARP Inhibitors for Cancer Therapy. PARP Inhibitors for Cancer Therapy
315
344
.
InYoung Kim & Yu-Ying He. (2014) Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation. Genes & Diseases 1:2, pages 188-198.
Crossref
Crossref
Julia L. Williams, Peter A. Greer & Jeremy A. Squire. (2014) Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data. Cancer Genetics 207:10-12, pages 474-488.
Crossref
Crossref
Julia A. Yaglom, Christopher McFarland, Leonid Mirny & Michael Y. Sherman. (2014) Oncogene-triggered suppression of DNA repair leads to DNA instability in cancer. Oncotarget 5:18, pages 8367-8378.
Crossref
Crossref
Barbara Lupo & Livio Trusolino. (2014) Inhibition of poly(ADP-ribosyl)ation in cancer: Old and new paradigms revisited. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:1, pages 201-215.
Crossref
Crossref
Arun Gupta, Clayton R. Hunt, Muralidhar L. Hegde, Sharmistha Chakraborty, Durga Udayakumar, Nobuo Horikoshi, Mayank Singh, Deepti B. Ramnarain, Walter N. Hittelman, Sarita Namjoshi, Aroumougame Asaithamby, Tapas K. Hazra, Thomas Ludwig, Raj K. Pandita, Jessica K. Tyler & Tej K. Pandita. (2014) MOF Phosphorylation by ATM Regulates 53BP1-Mediated Double-Strand Break Repair Pathway Choice. Cell Reports 8:1, pages 177-189.
Crossref
Crossref
Carolyn A. WorbyJack E. Dixon. (2014) PTEN. Annual Review of Biochemistry 83:1, pages 641-669.
Crossref
Crossref
Rachel Abbotts, Rosalyn Jewell, Jérémie Nsengimana, David J Maloney, Anton Simeonov, Claire Seedhouse, Faye Elliott, Jon Laye, Christy Walker, Ajit Jadhav, Anna Grabowska, Graham Ball, Poulam M Patel, Julia Newton-Bishop, David M WilsonIIIIII & Srinivasan Madhusudan. (2014) Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy. Oncotarget 5:10, pages 3273-3286.
Crossref
Crossref
Kathryn P. Pennington, Tom Walsh, Maria I. Harrell, Ming K. Lee, Christopher C. Pennil, Mara H. Rendi, Anne Thornton, Barbara M. Norquist, Silvia Casadei, Alexander S. Nord, Kathy J. Agnew, Colin C. Pritchard, Sheena Scroggins, Rochelle L. Garcia, Mary-Claire King & Elizabeth M. Swisher. (2014) Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas. Clinical Cancer Research 20:3, pages 764-775.
Crossref
Crossref
Izak Tait, Yan Li & Jun Lu. (2013) PTEN, Longevity and Age-Related Diseases. Biomedicines 1:1, pages 17-48.
Crossref
Crossref
Mary K. Leonard, Natasha T. Hill, Ethan D. Grant & Madhavi P. Kadakia. (2013) ΔNp63α represses nuclear translocation of PTEN by inhibition of NEDD4-1 in keratinocytes. Archives of Dermatological Research 305:8, pages 733-739.
Crossref
Crossref
Ananda Mukherjee, Sandip Misra, Niall G. Howlett & Parimal Karmakar. (2013) Multinucleation regulated by the Akt/PTEN signaling pathway is a survival strategy for HepG2 cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 755:2, pages 135-140.
Crossref
Crossref
Ananda Mukherjee & Parimal Karmakar. (2012) Attenuation of PTEN perturbs genomic stability via activation of Akt and down‐regulation of Rad51 in human embryonic kidney cells. Molecular Carcinogenesis 52:8, pages 611-618.
Crossref
Crossref
Adrian Danescu, Sandra Herrero Gonzalez, Antonio Di Cristofano, Sabine Mai & Sabine Hombach-Klonisch. (2013) Three-dimensional nuclear telomere architecture changes during endometrial carcinoma development. Genes, Chromosomes and Cancer 52:8, pages 716-732.
Crossref
Crossref
Gholamreza Bidkhori, Zahra Narimani, Saman Hosseini Ashtiani, Ali Moeini, Abbas Nowzari-Dalini & Ali Masoudi-Nejad. (2013) Reconstruction of an Integrated Genome-Scale Co-Expression Network Reveals Key Modules Involved in Lung Adenocarcinoma. PLoS ONE 8:7, pages e67552.
Crossref
Crossref
Ibrahim Hussain, Jean Anderson Eloy, Peter W. Carmel & James K. Liu. (2013) Molecular oncogenesis of craniopharyngioma: current and future strategies for the development of targeted therapies. Journal of Neurosurgery 119:1, pages 106-112.
Crossref
Crossref
Maike Ihnen, Christine zu Eulenburg, Teodora Kolarova, Jing Wei Qi, Kanthinh Manivong, Meenal Chalukya, Judy Dering, Lee Anderson, Charles Ginther, Alexandra Meuter, Boris Winterhoff, Siân Jones, Victor E. Velculescu, Natarajan Venkatesan, Hong-Mei Rong, Sugandha Dandekar, Nitin Udar, Fritz Jänicke, Gerrit Los, Dennis J. Slamon & Gottfried E. Konecny. (2013) Therapeutic Potential of the Poly(ADP-ribose) Polymerase Inhibitor Rucaparib for the Treatment of Sporadic Human Ovarian Cancer. Molecular Cancer Therapeutics 12:6, pages 1002-1015.
Crossref
Crossref
Justin L. Sparks, Rakesh Kumar, Mayank Singh, Marc S. Wold, Tej K. Pandita & Peter M. Burgers. (2012) Human Exonuclease 5 Is a Novel Sliding Exonuclease Required for Genome Stability. Journal of Biological Chemistry 287:51, pages 42773-42783.
Crossref
Crossref
C-H Yang, Y-H Kao, K-S Huang, C-Y Wang & L-W Lin. (2012) Cordyceps militaris and mycelial fermentation induced apoptosis and autophagy of human glioblastoma cells. Cell Death & Disease 3:11, pages e431-e431.
Crossref
Crossref
Gholamreza Bidkhori, Ali Moeini & Ali Masoudi-Nejad. (2012) Modeling of Tumor Progression in NSCLC and Intrinsic Resistance to TKI in Loss of PTEN Expression. PLoS ONE 7:10, pages e48004.
Crossref
Crossref
Sang Bum Kim, Raj K. Pandita, Ugur Eskiocak, Peter Ly, Aadil Kaisani, Rakesh Kumar, Crystal Cornelius, Woodring E. Wright, Tej K. Pandita & Jerry W. Shay. (2012) Targeting of Nrf2 induces DNA damage signaling and protects colonic epithelial cells from ionizing radiation. Proceedings of the National Academy of Sciences 109:43.
Crossref
Crossref
Amelia M. Huehls, Jill M. Wagner, Catherine J. Huntoon & Larry M. Karnitz. (2012) Identification of DNA Repair Pathways That Affect the Survival of Ovarian Cancer Cells Treated with a Poly(ADP-Ribose) Polymerase Inhibitor in a Novel Drug Combination. Molecular Pharmacology 82:4, pages 767-776.
Crossref
Crossref
James A. McCubrey, Linda S. Steelman, William H. Chappell, Stephen L. Abrams, Giuseppe Montalto, Melchiorre Cervello, Ferdinando Nicoletti, Paolo Fagone, Grazia Malaponte, Maria C. Mazzarino, Saverio Candido, Massimo Libra, Jörg Bäsecke, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Michele Milella, Agostino Tafuri, Lucio Cocco, Camilla Evangelisti, Francesca Chiarini & Alberto M. Martelli. (2012) Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades Which Alter Therapy Response.. Oncotarget 3:9, pages 954-987.
Crossref
Crossref
Sook Ryun Park & Alice Chen. (2012) Poly(Adenosine Diphosphate–Ribose) Polymerase Inhibitors in Cancer Treatment. Hematology/Oncology Clinics of North America 26:3, pages 649-670.
Crossref
Crossref
Mei Ming & Yu-Ying He. (2012) PTEN in DNA damage repair. Cancer Letters 319:2, pages 125-129.
Crossref
Crossref
Erik F Young, Lubomir B Smilenov, Howard B Lieberman & Eric J Hall. (2012) Combined Haploinsufficiency and Genetic Control of the G2/M Checkpoint in Irradiated Cells. Radiation Research 177:6, pages 743.
Crossref
Crossref
Jinqiang Hou, Frankie Lam, Christopher Proud & Shudong Wang. (2012) Targeting Mnks for Cancer Therapy. Oncotarget 3:2, pages 118-131.
Crossref
Crossref
Clayton R. Hunt, Arun Gupta, Nobuo Horikoshi & Tej K. Pandita. (2012) Does PTEN Loss Impair DNA Double-Strand Break Repair by Homologous Recombination?. Clinical Cancer Research 18:4, pages 920-922.
Crossref
Crossref
Michael Fraser, Helen Zhao, Kaisa R. Luoto, Cecilia Lundin, Carla Coackley, Norman Chan, Anthony M. Joshua, Tarek A. Bismar, Andrew Evans, Thomas Helleday & Robert G. Bristow. (2012)
PTEN
Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy
. Clinical Cancer Research 18:4, pages 1015-1027.
Crossref
Crossref
Mara Gladstone & Tin Tin Su. 2012. International Review of Cell and Molecular Biology Volume 299. International Review of Cell and Molecular Biology Volume 299
235
253
.
Mikhail V. Blagosklonny. (2011) NCI's provocative questions on cancer: some answers to ignite discussion. Oncotarget 2:12, pages 1352-1367.
Crossref
Crossref
Mikhail V. Blagosklonny. (2011) Molecular damage in cancer: an argument for mTOR-driven aging. Aging 3:12, pages 1130-1141.
Crossref
Crossref
James A. McCubrey, Linda S. Steelman, C. Ruth Kempf, William H. Chappell, Stephen L. Abrams, Franca Stivala, Graziella Malaponte, Ferdinando Nicoletti, Massimo Libra, Jörg Bäsecke, Danijela Maksimovic-Ivanic, Sanja Mijatovic, Giuseppe Montalto, Melchiorre Cervello, Lucio Cocco & Alberto M. Martelli. (2011) Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways. Journal of Cellular Physiology 226:11, pages 2762-2781.
Crossref
Crossref
Kim De Keersmaecker & Adolfo A. Ferrando. (2011) TLX1-Induced T-cell Acute Lymphoblastic Leukemia. Clinical Cancer Research 17:20, pages 6381-6386.
Crossref
Crossref
Jackson R. Taylor, Brian D. Lehmann, William H. Chappell, Stephen L. Abrams, Linda S. Steelman & James A. McCubrey. (2011) Cooperative Effects of Akt-1 and Raf-1 on the Induction of Cellular Senescence in Doxorubicin or Tamoxifen Treated Breast Cancer Cells. Oncotarget 2:8, pages 610-626.
Crossref
Crossref
Mei Ming, Li Feng, Christopher R. Shea, Keyoumars Soltani, Baozhong Zhao, Weinong Han, Robert C. Smart, Carol S. Trempus & Yu-Ying He. (2011) PTEN Positively Regulates UVB-Induced DNA Damage Repair. Cancer Research 71:15, pages 5287-5295.
Crossref
Crossref
Melissa L. SokoloskyKristin M. StadelmanWilliam H. Chappell, Stephen L. Abrams, Alberto M. Martelli, Franca Stivala, Massimo Libra, Ferdinando Nicoletti, Lyudmyla B. Drobot, Richard A. Franklin, Linda S. Steelman & James A. McCubrey. (2011) Involvement of Akt-1 and mTOR in Sensitivity of Breast Cancer to Targeted Therapy. Oncotarget 2:7, pages 538-550.
Crossref
Crossref
Martin D. Forster, Konstantin J. Dedes, Shahneen Sandhu, Sophia Frentzas, Rebecca Kristeleit, Alan Ashworth, Christopher J. Poole, Britta Weigelt, Stan B. Kaye & L. Rhoda Molife. (2011) Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nature Reviews Clinical Oncology 8:5, pages 302-306.
Crossref
Crossref
Linda S. Steelman, William H. Chappell, Stephen L. Abrams, C. Ruth Kempf, Jacquelyn Long, Piotr Laidler, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Franca Stivala, Maria C. Mazzarino, Marco Donia, Paolo Fagone, Graziella Malaponte, Ferdinando Nicoletti, Massimo Libra, Michele Milella, Agostino Tafuri, Antonio Bonati, Jörg Bäsecke, Lucio Cocco, Camilla Evangelisti, Alberto M. Martelli, Giuseppe Montalto, Melchiorre Cervello & James A. McCubrey. (2011) Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging 3:3, pages 192-222.
Crossref
Crossref
Timothy A. Yap, Shahneen K. Sandhu, Craig P. Carden & Johann S. de Bono. (2011) Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic. CA: A Cancer Journal for Clinicians 61:1, pages 31-49.
Crossref
Crossref
Josée Guirouilh-Barbat, Therese Wilhelm & Bernard S. Lopez. (2010) AKT1/BRCA1 in the control of homologous recombination and genetic stability: the missing link between hereditary and sporadic breast cancers. Oncotarget 1:8, pages 691-699.
Crossref
Crossref
Farah L. Rehman, Christopher J. Lord & Alan Ashworth. (2010) Synthetic lethal approaches to breast cancer therapy. Nature Reviews Clinical Oncology 7:12, pages 718-724.
Crossref
Crossref
Konstantin J. DedesDaniel WetterskogAna M. Mendes-PereiraRachael NatrajanMaryou B. LambrosFelipe C. GeyerRadost VatchevaKay SavageAlan MackayChristopher J. LordAlan AshworthJorge S. Reis-Filho. (2010) PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors. Science Translational Medicine 2:53.
Crossref
Crossref
Anthony J. Chalmers, Mina Lakshman, Norman Chan & Robert G. Bristow. (2010) Poly(ADP-Ribose) Polymerase Inhibition as a Model for Synthetic Lethality in Developing Radiation Oncology Targets. Seminars in Radiation Oncology 20:4, pages 274-281.
Crossref
Crossref
Zhaolu Kong, Daxing Xie, Thomas Boike, Pavithra Raghavan, Sandeep Burma, David J. Chen, Amyn A. Habib, Arup Chakraborty, Jer-Tsong Hsieh & Debabrata Saha. (2010) Downregulation of Human DAB2IP Gene Expression in Prostate Cancer Cells Results in Resistance to Ionizing Radiation. Cancer Research 70:7, pages 2829-2839.
Crossref
Crossref
Ana M. Mendes‐Pereira, Sarah A. Martin, Rachel Brough, Afshan McCarthy, Jessica R. Taylor, Jung‐Sik Kim, Todd Waldman, Christopher J. Lord & Alan Ashworth. (2009)
Synthetic lethal targeting of
PTEN
mutant cells with PARP inhibitors
. EMBO Molecular Medicine 1:6-7, pages 315-322.
Crossref
Crossref